Christa Pike Execution Fails: What Happened During Tennessee’s Botched Lethal Injection

Christa Pike survived Tennessee’s attempt to execute her by lethal injection on September 30, 2026, after the state administered two doses of pentobarbital but failed to cause her death. Witnesses reported that Pike continued breathing, speaking and making snoring sounds for more than an hour, while her lawyers later said the intravenous lines may have failed and allowed the drug to enter surrounding tissue rather than her bloodstream.

The execution began after a last-minute court fight delayed the scheduled 10 a.m. procedure until the evening. Pike was eventually taken from the death chamber by ambulance and hospitalized in critical condition. Her attorneys said she was unconscious and on a ventilator, with both arms swollen, burned and blistered. Tennessee officials have maintained that the execution team followed the state’s established protocol, while an independent review is now examining why the procedure failed.

What happened during Christa Pike’s execution

Pike, 50, was scheduled to die at Riverbend Maximum Security Institution in Nashville for the 1995 murder of 19-year-old Colleen Slemmer, a fellow Job Corps participant. Pike was 18 when Slemmer was killed.

The September 30 execution was already unusual before the lethal injection began. A federal appeals court temporarily stayed the execution on the morning of the scheduled date while considering Pike’s arguments concerning her childhood sexual abuse and the effect of that history on her sentencing. Tennessee appealed to the U.S. Supreme Court, which later vacated the stay and allowed the execution to proceed.

That legal delay pushed the execution from its scheduled morning start to roughly 7:30 p.m.

Once the execution chamber was opened to witnesses, Pike was strapped to a gurney with an IV in her arm. She had been permitted to make a final statement and told witnesses she was leaving the world with love. She also sang with her spiritual adviser.

Then the medical procedure began.

The execution timeline

The times come primarily from accounts by media witnesses and subsequent court filings; Tennessee has not publicly released a complete independent reconstruction of every medical action inside the execution chamber.

Why the lethal injection appears to have failed

Tennessee uses pentobarbital in its lethal-injection protocol. The state says the drug has consistently been effective and that its execution team followed the approved procedure in Pike’s case.

Pike’s attorneys dispute what happened.

According to an emergency court filing, the execution team struggled to establish intravenous access. Her lawyers said they counted at least seven needle attempts in her left arm and had previously warned that Pike’s small veins and a blood disorder called thrombocytosis could make IV access difficult.

Their central allegation is that the IV lines were not properly positioned—or that the veins had failed—and that pentobarbital therefore entered tissue rather than being delivered effectively into the bloodstream. They say the problem was not recognized before a second dose was administered.

That explanation remains an allegation from Pike’s legal team, not a final finding by an independent investigation.

What is established is that Pike received two doses and survived them. The Tennessee Department of Correction has not publicly provided a detailed medical explanation for why the drugs failed to produce death.

What happened to Pike’s arms

The physical condition described after the execution provides an important clue to the dispute over the IV lines.

Pike’s attorneys said she arrived at the hospital with both arms swollen, burned and blistered. They said hospital staff were treating the serious effects of pentobarbital and attempting to clear the drug from her system.

An anesthesiologist retained by the defense, Dr. Joel Zivot, told reporters that the injuries were consistent with pentobarbital leaking into tissue outside a vein. That is an expert opinion offered on behalf of Pike’s legal team, rather than an official finding about the execution.

Pentobarbital is a barbiturate that depresses the central nervous system. In Tennessee’s protocol, it is intended to cause unconsciousness followed by death. The crucial issue in Pike’s case is therefore not simply whether the state administered the drug, but where the drug went and whether enough of it reached the bloodstream to produce the intended physiological effect.

That distinction is central to understanding why two injections did not result in death.

What witnesses heard inside the death chamber

The execution was witnessed by journalists, including Associated Press and local television reporters.

Their accounts describe Pike initially interacting with her spiritual adviser and later complaining that her arm hurt. After the drug administration, she appeared to lose consciousness, but she continued breathing.

Witnesses subsequently heard a repetitive breathing or snoring sound from behind the curtain. The sound continued for a prolonged period, including after the second dose. Eventually, prison officials ordered the witnesses to leave.

The significance of the breathing is straightforward: it indicated that Pike was still alive when the execution was expected to have been completed.

The precise level of her consciousness during different portions of the procedure is less certain. Witnesses could hear sounds and observe some movements, but they could not see everything happening once the curtain was closed.

Why a second dose was given

Tennessee’s protocol anticipates the possibility that the first dose will not immediately result in death. Its procedure calls for a second administration of pentobarbital if the prisoner remains alive after the initial dose.

That is why the second dose is important in Pike’s case.

The problem was not simply that a first dose appeared ineffective. The extraordinary event was that Pike remained alive after the backup dose as well.

According to USA Today, Tennessee’s protocol does not appear to contain a procedure specifically addressing a situation in which two doses fail to produce death. That raises a separate question from whether the first IV placement was technically successful: what should an execution team do when its established procedure reaches an outcome it was not designed to handle?

That question will be among the important issues for investigators.

Pike had warned that IV access could be difficult

The failure did not occur without prior warnings.

Before her execution, Pike challenged Tennessee’s lethal-injection method in court. Her filings raised concerns about her medical conditions, including thrombocytosis and small veins that could make needle placement difficult. Her lawyers argued that these circumstances created an elevated risk of pain and complications during lethal injection.

Those arguments were unsuccessful, and courts ultimately allowed the execution to proceed.

That does not establish that the medical concerns caused the failed execution. It does, however, make the question of how the execution team prepared for known IV-access difficulties particularly important to the subsequent investigation.

The distinction matters: Pike’s medical history is documented; the precise causal connection between that history, the IV failures and the failed execution remains to be established.

What Tennessee says happened

The Tennessee Department of Correction’s immediate public position was that it followed its lawful, established execution protocol.

In its September 30 statement, the department said the protocol had been followed and that it did not permit additional procedures beyond those carried out that evening. It also confirmed that Pike had been transported to an off-site medical facility.

Governor Bill Lee subsequently ordered an independent review and halted the remaining executions scheduled for 2026. He said the state needed to determine why the outcome in Pike’s case differed from previous executions despite the state’s assertion that its protocol had been followed.

The review is therefore especially important because the two sides are not currently offering the same explanation. Tennessee says the established procedure was followed; Pike’s lawyers say the procedure failed at the level of IV access and that the failure was not recognized before the second dose was given.

How unusual was Pike’s survival?

Extremely unusual.

The Death Penalty Information Center described Pike as the first known person to remain alive after lethal-injection drugs were administered as part of an execution attempt.

Botched executions are not new in the United States. Problems with establishing intravenous access have caused states to delay or abandon executions before. Tennessee itself halted an execution attempt involving Tony Ray Carruthers in May 2026 after officials could not establish a backup IV line.

But Pike’s case is different in a critical respect: the state proceeded far enough to administer two doses of the lethal drug, yet the prisoner survived and required emergency hospitalization.

That makes the case more than a failed attempt to establish an IV. It raises questions about drug delivery, monitoring, decision-making after the first dose, and what safeguards exist when the expected physiological response does not occur.

What remains unknown

Several important details cannot yet be stated as established fact.

It is not publicly clear exactly when each IV line was placed, whether either line was confirmed to be functioning adequately before the drug was administered, or precisely how much pentobarbital entered Pike’s bloodstream.

It is also not yet established whether the drug itself was defective, improperly stored, improperly administered, or simply failed to reach the bloodstream in sufficient quantity. The state has said its lethal-injection chemical has consistently been effective, while the investigation has not yet produced a public technical finding explaining the failure.

Pike’s long-term medical condition was also still uncertain in the latest public reports. Her attorneys said she was critically ill, unconscious and on a ventilator, with hospital staff treating the effects of the pentobarbital and her arm injuries.

Those details could change as medical records, execution-team records and other evidence are reviewed.

The immediate legal and practical questions

Pike’s lawyers filed an emergency motion seeking preservation of evidence from the execution, including records and materials that could establish what happened inside the chamber. That evidence could become important in future litigation over the procedure and Pike’s sentence.

There is also a fundamental question about what happens to Pike’s death sentence after an execution attempt has failed.

For now, Tennessee has not carried out a second attempt. The governor has halted executions for the remainder of 2026 while the review proceeds. Whether Pike could legally be subjected to another execution attempt, and under what circumstances, would depend on subsequent medical, legal and judicial developments.

The more immediate issue is determining what actually happened on September 30. That requires separating what witnesses saw and heard from what occurred behind the closed curtain, and separating the defense’s medical explanation from findings that have yet to be independently established.

What the Pike case will ultimately test

The most consequential question is not simply why pentobarbital failed to kill Christa Pike. It is whether Tennessee’s execution system was capable of recognizing and safely responding to a failure while the procedure was still underway.

The known sequence is stark: a delayed execution, difficult IV access, two doses of pentobarbital, continued breathing, prolonged sounds from the chamber, emergency medical intervention and hospitalization. The state says its protocol was followed; Pike’s attorneys allege that the IV access failed and that the second dose compounded the problem.

An independent review now has to determine which parts of that account are supported by medical and operational evidence. Until that work is complete, the safest conclusion is also the simplest: Tennessee successfully administered the drugs it intended to use, but it did not successfully carry out the execution—and the reason remains an unresolved factual question with potentially profound legal consequences.